TIMM22 and mitochondrial disease: Therefore, the identification of a novel mutation in TIM22 is a key not only for a better understanding of the mechanisms leading to metabolite carrier import in human mitochondria, but also to dig further into the pathological roles of the loss of carrier proteins in mitochondrial disease.